Ralph del Campo
2010
In 2010, Ralph del Campo earned a total compensation of $1.2M as Chief Operating Officer and Principal Executive Officer at Enzon Pharmaceuticals, a 114% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $444,370 |
|---|---|
| Salary | $472,035 |
| Stock Awards | $288,504 |
| Other | $29,988 |
| Total | $1,234,897 |
del Campo received $472K in salary, accounting for 38% of the total pay in 2010.
del Campo also received $444.4K in non-equity incentive plan, $288.5K in stock awards and $30K in other compensation.
Rankings
In 2010, Ralph del Campo's compensation ranked 4,564th out of 10,439 executives tracked by ExecPay. In other words, del Campo earned more than 56.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,564 out of 10,439 | 56th |
Division Manufacturing | 1,633 out of 3,838 | 58th |
Major group Chemicals And Allied Products | 331 out of 921 | 64th |
Industry group Drugs | 184 out of 680 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 33 out of 142 | 77th |
Source: SEC filing on April 8, 2011.
del Campo's colleagues
We found five more compensation records of executives who worked with Ralph del Campo at Enzon Pharmaceuticals in 2010.
2010
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2010
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2010
Paul Davit
Enzon Pharmaceuticals
Executive Vice President, Human Resources and Administration
2010
Mark Ogden
Enzon Pharmaceuticals
Acting Vice President, Finance and Principal Financial Officer
2010
Craig Tooman
Enzon Pharmaceuticals